Research helps unlock gene secrets of autosomal dominant nocturnal frontal lobe epilepsy

Research helps unlock gene secrets of autosomal dominant nocturnal frontal lobe epilepsy

In a national research partnership, Dr Sarah Heron from the University of South Australia's Sansom Research Institute, epilepsy research group, has been working to map the genes responsible for a rare form of epilepsy - autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).

Dr Heron and her team's latest research to identify a new gene for this form of epilepsy has been published in this month.  

She says while ADNFLE affects a relatively rare group of people, the symptoms and impact of the condition can be devastating.

"ADNFLE usually develops in childhood and characterised by clusters of seizures during sleep," Dr Heron says.

 "It can have an association with cognitive deficits and or psychiatric comorbidity.

 "Our research has identified that mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy and associated intellectual and or psychiatric disability."

UniSA's epilepsy research group is led by Associate Professor Leanne Dibbens.  The gener-discovery research has been undertaken with support from the National Health and Medical Research Council of Australia and in collaboration with researchers at The University of Melbourne's Clinical College's Epilepsy Research Centre.

Dr Heron says the identification of the gene has important implications for and also for understanding more about the full spectrum of epilepsy disorders.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

No danger of cancer through gene therapy virus

20 hours ago

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

The secret of DNA methylation

Jun 18, 2013

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression ...

Aspirin may fight cancer by slowing DNA damage

Jun 18, 2013

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

User comments

More news stories

New research shows metaphors reveal personality

(Medical Xpress)—A new study by Adam K. Fetterman, a recent doctoral graduate in psychology, and Michael D. Robinson, professor of psychology at North Dakota State University, shows that metaphors for the head and the heart ...

Empowering children in clinical trials

There is evidence that over 50 percent of medicinal products developed for children have not been tested or authorised for use by this age group. The research project RESPECT ('Relating Expectations and Needs ...